NxStage Medical Inc.’s (NSDQ:NXTM) Medisystems division signed a Tennessee-based medical products supplier to expand its sales reach.
NxStage, which develops home hemodialysis products, has posted rising sales and decreasing losses in recent quarters.
It posted a loss of $8.2 million, or 17 cents per diluted share, on sales of $45.0 million during the three months ended Sept. 30. That compares with a loss of $10.0 million, or 22 cents per diluted share, on sales of $38.0 million during the same period last year. Second-quarter red ink narrowing 34 percent on a nearly 21 percent top-line spike.
The new deal means the Lawrence, Mass.-based company begins distributing its in-center therapy products through Nashville-based Metro Medical Supply Inc., according to NxStage.
Last week, the company closed an IPO from which it grossed $66.1 million.
